December 17, 2020

BONESUPPORT moves to Mid Cap

Lund, Sweden, 11.00 CET, Dec 17, 2020 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, will be moved to the Mid Cap segment on Nasdaq Stock...
Read more
December 17, 2020

Spruce Biosciences Added to Russell 2000®, 3000® and Microcap® Indexes

SAN FRANCISCO--(BUSINESS WIRE)--Dec. 17, 2020-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel th...
Read more
December 15, 2020

Vicore Pharma announces Last Patient Last Visit in the mechanistic phase II study with C21 in systemic sclerosis

Gothenburg, December 15, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for serious lung disorders, today annou...
Read more
December 10, 2020

Fusion Pharmaceuticals Initiates Multi-Dose Portion Of Phase 1 Trial Of FPI-1434 In Patients With Advanced Solid Tumors

Phase 1 Single-Dose Data Show Uptake Across Multiple Tumor Types; No Dose Limiting Toxicities or Treatment-Related Serious Adverse Events HAMILTON, ON and BOSTON, Dec. 10...
Read more
December 10, 2020

GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine

First publication based on Phase III data to document sustained and clinically meaningful bilateral improvement in visual acuity from unilateral injection of a gene therapy ...
Read more
December 9, 2020

Full data set of Oncopeptides phase 2 HORIZON study in multiple myeloma published in the Journal of Clinical Oncology

STOCKHOLM — December 9, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-...
Read more
December 8, 2020

Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19

2020-12-08 Oral C21 treatment demonstrates significant clinical improvement on top of corticosteroids Gothenburg, December 08, 2020 – Vicore Pharma Holding AB (publ), a phar...
Read more
December 7, 2020

Oncopeptides will host a webcast on Wednesday, December 9[th] at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting

STOCKHOLM — December 7, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-...
Read more
December 7, 2020

Orexo Enters Exclusive License and Supply Agreement with Accord Healthcare for ZUBSOLV[® ]in Europe

The agreement covers 29 countries in Europe Orexo will receive double-digit royalties on future net sales First launches are expected in H2, 2021 Uppsala, Sweden – D...
Read more
December 6, 2020

Oncopeptides presents new data from phase 2 ANCHOR combination study in multiple myeloma at American Society of Hematology meeting ASH

STOCKHOLM — December 6, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-t...
Read more